Wybrane publikacje

  1. Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, Di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW. Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial. EuroIntervention. 2011 Sep;7(5):605-13.

  2. Dębiński M, Buszman PP, Milewski K, Wojakowski W, Jackiewicz W, Pająk J, Szurlej D, Fryc-Stanek J, Wiernek S, Jelonek M, Spurlock ME, Martin J, Bochenek A, Buszman PE. Intracoronary adiponectin at reperfusion reduces infarct size in a porcine myocardial infarction model. Int J Mol Med. 2011 Jun;27(6):775-81. doi: 10.3892/ijmm.2011.643. Epub 2011 Mar 8.

  3. Stefanini GG, Serruys PW, Silber S, Khattab AA, van Geuns RJ, Richardt G, Buszman PE, Kelbæk H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, Di Mario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli AL, Gobbens P, Windecker S. The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention). J Am Coll Cardiol. 2011 May 31;57(22):2221-32.

  4. Klauss V, Serruys PW, Pilgrim T, Buszman P, Linke A, Ischinger T, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, van Geuns RJ, van Es GA, Kalesan B, Wenaweser P, Jüni P, Windecker S. 2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice. JACC Cardiovasc Interv. 2011 Aug;4(8):887-95.

  5. Garg S, Serruys PW, Silber S, Wykrzykowska J, van Geuns RJ, Richardt G, Buszman PE, Kelbæk H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Van Remortel E, Ronden J, Windecker S. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv. 2011 Apr;4(4):432-41.

  6. Radwan K, Peszek-Przybyła E, Buszman P, Sosnowski M. A case of multiple giant right coronary artery aneurysms. Cardiol J. 2011;18(4):434-6.

  7. Milewski K, Zurakowski A, Pajak J, Liszka L, Debinski M, Buszman PP, Samra MA, Dominek P, Aboodi MS, Kaluza GL, Buszman P. Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model. Cardiovasc Revasc Med. 2011 Mar-Apr;12(2):82-9. Epub 2010 Oct 20.

  8. Garg S, Wykrzykowska J, Serruys PW, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Tyczynski P, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Jüni P, Windecker S. The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer. EuroIntervention. 2011 Mar;6(8):928-35.

  9. Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Goedhart D, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trial. Circ Cardiovasc Interv. 2011 Feb 1;4(1):47-56. Epub 2011 Jan 4.

  10. Kiesz RS, Wiernek BK, Wiernek SL, Merritt C, Ybarra T, Iwanski A, Buszman PP, Szymanski R, Martin JL, Buszman PE. Cardiva Catalyst II vascular access management device in percutaneous diagnostic and interventional procedures with same-day discharge (Catalyst II trial). J Endovasc Ther. 2011 Feb;18(1):46-53.

  11. Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol. 2010 Jul 20;56(4):272-7.

  12. Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med. 2010 Jul 8;363(2):136-46. Epub 2010 Jun 16.

  13. Wojakowski W, Tendera M, Kucia M, Zuba-Surma E, Milewski K, Wallace-Bradley D, Kazmierski M, Buszman P, Hrycek E, Cybulski W, Kaluza G, Wieczorek P, Ratajczak J, Ratajczak MZ. Cardiomyocyte differentiation of bone marrow-derived Oct-4+CXCR4+SSEA-1+ very small embryonic-like stem cells. Int J Oncol. 2010 Aug;37(2):237-47.

  14. Garg S, Sarno G, Serruys PW, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, Di Mario C, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Jüni P, Windecker S. The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. EuroIntervention. 2010 Jun;6(2).

  15. Buszman P, Milewski K, Zurakowski A, Pajak J, Liszka Ł, Buszman P, Musioł E, AbuSamra M, Trznadel S, Kałuza G. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries. Kardiol Pol. 2010 May;68(5):503-9.

  16. Latacz P, Rostoff P, Rudnik A, Kondys M, Buszman P. Percutaneous revascularisation of subacute occlusion of the left subclavian artery manifesting as acute coronary syndrome in a patient after coronary artery bypass grafting. Kardiol Pol. 2010 Feb;68(2):226-9; discussion 230-1. Polish.

  17. Milewski K, Zurakowski A, Pajak J, Pajak-Zielinska E, Liszka L, Buszman PP, Bis J, Debinski M, Buszman PE. Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia. Med Sci Monit. 2010 Jan;16(1):BR40-4.

  18. Sarno G, Garg S, Onuma Y, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, van Geuns RJ, Eerdmans P, Garcia-Garcia HM, van Es GA, Goedhart D, de Vries T, Jüni P, Meier B, Windecker S, Serruys P. The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial). Am J Cardiol. 2010 Feb 15;105(4):475-9. Epub 2010 Jan 5.

  19. Berger JS, Roe MT, Gibson CM, Kilaru R, Green CL, Melton L, Blankenship JD, Metzger DC, Granger CB, Gretler DD, Grines CL, Huber K, Zeymer U, Buszman P, Harrington RA, Armstrong PW. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial. Am Heart J. 2009 Dec;158(6):998-1004.e1.

  20. Buszman PP, Bochenek A, Konkolewska M, Trela B, Kiesz RS, Wilczyński M, Cisowski M, Krejca M, Banasiewicz-Szkróbka I, Krol M, Kondys M, Wiernek S, Orlik B, Martin JL, Tendera M, Buszman PE. Early and long-term outcomes after surgical and percutaneous myocardial revascularization in patients with non-ST-elevation acute coronary syndromes and unprotected left main disease. J Invasive Cardiol. 2009 Nov;21(11):564-9.

  21. Buszman PE, Buszman PP, Kiesz RS, Bochenek A, Trela B, Konkolewska M, Wallace-Bradley D, Wilczyński M, Banasiewicz-Szkróbka I, Peszek-Przybyla E, Krol M, Kondys M, Milewski K, Wiernek S, Debiński M, Zurakowski A, Martin JL, Tendera M. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. J Am Coll Cardiol. 2009 Oct 13;54(16):1500-11. Epub 2009 Aug 21.

  22. Zembala M, Wilczek K, Przybylski R, Chodór P, Nadziakiewicz P, Krasoń M, Sadowski J, Dudek D, Kapelak B, Forysz D, Witkowski A, Demkow M, Chmielak Z, Kuśmierski K, Juraszyński Z, Bochenek A, Cisowski M, Trusz-Gluza M, Buszman P, Woś S, Kalarus Z, Poloński L, Gasior M, Opolski G, Ruzyłło W. POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities.  Kardiol Pol. 2009 Aug;67(8):936-40. Polish.

  23. Wykrzykowska JJ, Serruys PW, Onuma Y, de Vries T, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. JACC Cardiovasc Interv. 2009 Sep;2(9):861-70.

  24. Buller CE, Rankin JM, Carere RG, Buszman PE, Pfisterer ME, Dzavik V, Thomas B, Forman S, Ruzyllo W, Mancini GB, Michalis LK, Abreu PF, Lamas GA, Hochman JS. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years. Am Heart J. 2009 Sep;158(3):408-15.

  25. Peszek-Przybyła E, Radwan K, Gruszka A, Krejca M, Buszman P, Sosnowski M. Sinus of Valsalva aneurysm. Cardiol J. 2009;16(5):455-7.

  26. V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Regar E, Jüni P, Windecker S, Serruys PW. Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy. EuroIntervention. 2009 Aug;5(3):310-7.

  27. Zurakowski A, Wojakowski W, Dzielski T, Milewski K, Gościńska-Bis K, Tendera M, Buszman P. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting. Kardiol Pol. 2009 Jun;67(6):623-30.

  28. Dzavík V, Buller CE, Devlin G, Carere RG, Mancini GB, Cantor WJ, Buszman PE, Rankin JM, Vozzi C, Ross JR, Forman S, Barton BA, Lamas AG, Hochman JS. Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial. Catheter Cardiovasc Interv. 2009 May 1;73(6):771-9.

  29. Debiński M, Zurakowski A, Buszman P. Primary percutaneous coronary intervention complicated by left anterior descending artery perforation - a case report. Kardiol Pol. 2009 Apr;67(4):446-8; discussion 449-50. Polish.

  30. Spargias K, Milewski K, Debinski M, Buszman PP, Cokkinos DV, Pogge R, Buszman P. Drug delivery at the aortic valve tissues of healthy domestic pigs with a Paclitaxel-eluting valvuloplasty balloon. J Interv Cardiol. 2009 Jun;22(3):291-8. Epub 2009 May 13.

  31. Król M, Skwarna B, Buszman P. Successful recanalisation of RCA CTO using retrograde approach. Kardiol Pol. 2009 Mar;67(3):326-9; discussion 330. Polish.

  32. Buszman P, Wiernek S, Szymanski R, Bialkowska B, Buszman P, Fil W, Stables R, Bochenek A, Martin J, Tendera M. Percutaneous versus surgical revascularization for multivessel coronary artery disease: a single center 10 year follow-up of SOS trial patients. Catheter Cardiovasc Interv. 2009 Sep 1;74(3):420-6.

  33. Tendera M, Wojakowski W, Ruzyłło W, Chojnowska L, Kepka C, Tracz W, Musiałek P, Piwowarska W, Nessler J, Buszman P, Grajek S, Breborowicz P, Majka M, Ratajczak MZ; REGENT Investigators. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 2009 Jun;30(11):1313-21. Epub 2009 Feb 10.

  34. Buszman P, Zurakowski A, Bochenek T, Milewski K. Percutaneous closure of a congenital coronary artery fistula with the use of graftstent - a case report. Kardiol Pol. 2008 Dec;66(12):1342-4. Polish.

  35. Wojakowski W, Tendera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J, Hałasa M, Król M, Kazmierski M, Buszman P, Ochała A, Ratajczak J, Machaliński B, Ratajczak MZ. Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol. 2009 Jan 6;53(1):1-9.

  36. Serruys PW, García-García HM, Buszman P, Erne P, Verheye S, Aschermann M, Duckers H, Bleie O, Dudek D, Bøtker HE, von Birgelen C, D'Amico D, Hutchinson T, Zambanini A, Mastik F, van Es GA, van der Steen AF, Vince DG, Ganz P, Hamm CW, Wijns W, Zalewski A; Integrated Biomarker and Imaging Study-2 Investigators. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation. 2008 Sep 9;118(11):1172-82. Epub 2008 Sep 1.

  37. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Davies S, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Jüni P. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet. 2008 Sep 27;372(9644):1163-73. Epub 2008 Aug 31.

  38. Meliga E, Valgimigli M, Buszman P, Serruys PW. Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate. J Am Coll Cardiol. 2008 Aug 12;52(7):582-4; author reply 584-6.

  39. Radwan K, Peszek-Przybyła E, Gruszka A, Sosnowski M, Buszman P. Acute aortic dissection imitating ST elevation myocardial infarction with accompanying pulmonary embolism. Cardiol J. 2007;14(6):595-6. No abstract available.

  40. Buszman P, Debiński M, Gruszka A, Janas P, Król M, Kondys M, Iwiński J, Kazibutowska-Zarańska Z, Cierpka L, Tendera M. Early and late outcomes of percutaneous transluminal angioplasty of cephalad arteries. Kardiol Pol. 2008 Mar;66(3):233-42, discussion 243.

  41. Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski M, Bialkowska B, Dudek D, Gruszka A, Zurakowski A, Milewski K, Wilczynski M, Rzeszutko L, Buszman P, Szymszal J, Martin JL, Tendera M. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol. 2008 Feb 5;51(5):538-45.

  42. Buszman P, Trznadel S, Milewski K, Rzeźniczak J, Przewłocki T, Kośmider M, Wójcik J, Janczak J, Zurakowski A, Kondys M, Król M, Kinasz L, Jaklik A, Rzeszutko Ł, Kałuza GL, Kiesz S, Gil R. Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry. Catheter Cardiovasc Interv. 2008 Jan 1;71(1):51-7.

  43. Latacz P, Rostoff P, Wyderka R, Rudnik A, Kondys M, Marut A, Buszman P, Piwowarska W. Massive pulmonary embolism mimicking ST-elevation acute coronary syndrome successfully treated with hybrid therapy in a trauma patient receiving nadroparin: diagnostic and therapeutic dilemmas. Kardiol Pol. 2007 Oct;65(10):1235-42, discussion 1242-3. Polish.

  44. Buszman P, Trznadel S, Zurakowski A, Milewski K, Kinasz L, Król M, Kondys M. Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions. Kardiol Pol. 2007 Sep;65(9):1041-6; discussion 1047-8.

  45. Stillman AE, Oudkerk M, Ackerman M, Becker CR, Buszman PE, de Feyter PJ, Hoffmann U, Keadey MT, Marano R, Lipton MJ, Raff GL, Reddy GP, Rees MR, Rubin GD, Schoepf UJ, Tarulli G, van Beek EJ, Wexler L, White CS. Use of multidetector computed tomography for the assessment of acute chest pain: a consensus statement of the North American Society of Cardiac Imaging and the European Society of Cardiac Radiology. Eur Radiol. 2007 Aug;17(8):2196-207. Epub 2007 Jun 5.

  46. Latacz P, Rostoff P, Gutowska O, Kondys M, Buszman P, Piwowarska W. Prolonged successful resuscitation with simultaneous complex angioplasty of the left anterior descending coronary artery in acute myocardial infarction complicated by cardiogenic shock--a case report. Kardiol Pol. 2007 Jun;65(6):691-6; discussion 696-7. Polish.

  47. Stillman AE, Oudkerk M, Ackerman M, Becker CR, Buszman PE, de Feyter PJ, Hoffmann U, Keadey MT, Marano R, Lipton MJ, Raff GL, Reddy GP, Rees MR, Rubin GD, Schoepf UJ, Tarulli G, van Beek EJ, Wexler L, White CS; North American Society of Cardiac Imaging; European Society of Cardiac Radiology. Use of multidetector computed tomography for the assessment of acute chest pain: a consensus statement of the North American Society of Cardiac Imaging and the European Society of Cardiac Radiology. Int J Cardiovasc Imaging. 2007 Aug;23(4):415-27. Epub 2007 May 10.

  48. Buszman P, Debiński M, Noga A, Kuligowski A, Bochenek T, Milewski K. Percutaneous ablation of the segmental renal artery for the treatment of the arterio-pelvic fistula complicating percutaneous nephrolithotomy--a case report. Kardiol Pol. 2006 Dec;64(12):1419-21. Polish.

  49. Buszman P, Szkróbka I, Gruszka A, Parma R, Tendera Z, Leśko B, Wilczyński M, Bochenek T, Wojakowski W, Bochenek A, Tendera M. Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy. Am J Cardiol. 2007 Jan 1;99(1):36-41. Epub 2006 Nov 3.

  50. Debiński M, Milewski K, Stachaczyk L, Buszman P. Staged percutaneous coronary angioplasty as a therapy of choice in three-vessel coronary disease in a patient with serious contraindications for coronary artery bypass grafting surgery - a case report. Kardiol Pol. 2006 Nov;64(11):1292-6. Polish.

  51. Fox K, García MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, de Backer G, Hjemdahl P, López-Sendón J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K; Grupo de trabajo de la sociedad europea de cardiologia sobre el manejo de la angina estable. Guidelines on the management of stable angina pectoris. Executive summary. Rev Esp Cardiol. 2006 Sep;59(9):919-70.

  52. Dzavík V, Buller CE, Lamas GA, Rankin JM, Mancini GB, Cantor WJ, Carere RJ, Ross JR, Atchison D, Forman S, Thomas B, Buszman P, Vozzi C, Glanz A, Cohen EA, Meciar P, Devlin G, Mascette A, Sopko G, Knatterud GL, Hochman JS; TOSCA-2 Investigators. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation. 2006 Dec 5;114(23):2449-57. Epub 2006 Nov 14.

  53. Task Force per il Trattamento dell'Angina Pectoris Stabile della Società Europea di Cardiologia, Fox K, Alonso Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Osterspey A, Tamargo J, Zamorano JL, Andreotti F, Becher H, Dietz R, Fraser A, Gray H, Hernandez Antolin RA, Huber K, Kremastinos DT, Maseri A, Nesser HJ, Pasierski T, Sigwart U, Tubaro M, Weis M. Guidelines on the management of stable angina pectoris: executive summary. G Ital Cardiol (Rome). 2006 Aug;7(8):535-83. Italian. No abstract available.

  54. Buszman P, Zurakowski A, Banasiewicz-Szkróbka I, Peszek-Przybyła E, Gościńska-Bis K, Debiński M, Trusz-Gluza M. Percutaneous Transluminal Coronary Angioplasty of unprotected left main coronary artery in patient with severe left ventricular contractility dysfunction. Kardiol Pol. 2006 Sep;64(9):1018-20; discussion 1020.

  55. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygsen K; European Society of Cardiology. Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris. Kardiol Pol. 2006 Aug;64(8):823-80. Polish. No abstract available.

  56. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL; Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006 Jun;27(11):1341-81. Epub 2006 May 30.

  57. Buszman P, Zurakowski A, Gruszka A, Szkróbka I, Peszek-Przybyła E, Radwan K, Milewski K, Barteczko Z, Tendera M. Local paclitaxel delivery as a treatment of persistent, recurrent in-stent restenosis -- safety assessment. Kardiol Pol. 2006 Mar;64(3):268-72.

  58. Peszek-Przybyła E, Buszman P, Białkowska B, Zurakowski L, Banasiewicz-Szkróbka I, Debiński M, Tendera M. Stent implantation for the unprotected left main coronary artery. The long-term outcome of 62 patients. Kardiol Pol. 2006 Jan;64(1):1-6; discussion 7.

  59. Buszman P. Angiography and angioplasty of peripheral arteries. Kardiol Pol. 2005 Nov;63(5 Suppl 3):S543-4. 

  60. Buszman P, Szkróbka I, Tendera Z, Gruszka A, Bialkowska B, Parma R, Wojakowski W, Król M, Kiesz SR, Bochenek A, Tendera M. Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry). EuroIntervention. 2005 Aug;1(2):186-92.

  61. Buszman P, Zurakowski A, Kinasz L, Gorycki B, Król M, Lewicki A, Flak Z, Milewski K, Zurek P. The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty. Kardiol Pol. 2005 May;62(5):451-9;

  62. Zakliczynski M, Swierad M, Zakliczynska H, Maruszewski M, Buszman P, Zembala M. Usefulness of stanford scale of intimal hyperplasia assessed by intravascular ultrasound to predict time of onset and severity of cardiac allograft vasculopathy. Transplant Proc. 2005 Mar;37(2):1343-5.

  63. Termin-Pośpiech A, Buszman P, Tendera M. Procedures of invasive cardiology performed in ambulatory care. Kardiol Pol. 2005 Feb;62(2):157-60. Review.

  64. Serruys PW, Ormiston JA, Sianos G, Sousa JE, Grube E, den Heijer P, de Feyter P, Buszman P, Schömig A, Marco J, Polonski L, Thuesen L, Zeiher AM, Bett JH, Suttorp MJ, Glogar HD, Pitney M, Wilkins GT, Whitbourn R, Veldhof S, Miquel K, Johnson R, Coleman L, Virmani R; ACTION investigators. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J Am Coll Cardiol. 2004 Oct 6;44(7):1363-7.

  65. Zakliczyński M, Lekston A, Swierad M, Wnek A, Buszman P, Przybylski R, Wojarski J, Przybylski J, Foremny J, Poloński L, Zembala M. Coronary artery disease in heart transplant recipients - diagnosis and treatment. Single centre experience based on results of elective coronary angiography. Kardiol Pol. 2003 Feb;58(2):109-20.

  66. Maślankiewicz K, Jaklik A, Jakubowski D, Kośmider J, Ochała A, Skowerski M, Wita K, Weglarz P, Zaorski K, Buszman P, Drzewiecki J, Gasior Z, Gross M, Trusz-Gluza M, Tendera M. Results of treating myocardial infarction patients with ST segment elevation in Górnoślaskim Ośrodku Kardiologii in Katowice. Kardiol Pol. 2003 Jun;58 Suppl 4:IV19-24. Polish.

  67. Kiesz RS, Buszman P, Martin JL, Deutsch E, Rozek MM, Gaszewska E, Rewicki M, Seweryniak P, Kosmider M, Tendera M. Local delivery of enoxaparin to decrease restenosis after stenting: results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment study (The POLONIA study). Circulation. 2001 Jan 2;103(1):26-31.

  68. Buszman PP, Szymański R, Dębiński M, Milewski K, Król M, Nowakowski P, Kiesz RS, Radvany MG, Wiernek S, Wiernek B, Buszman PE; Long-term results of cephalad arteries percutanoeus transluminal angioplasty with stent implantation (The CAPTAS registry); Catheter Cardiovasc Interv. 2012 Mar 1;79(4):532-40. doi: 10.1002/ccd.23391. Epub 2012 Feb 6.

  69. Buszman PP, Wojakowski W, Milewski K, Dębiński M, Pająk J, Aboodi MS, Jackiewicz W, Kawka M, Bochenek A, Prats J, Granada JF, Kałuża GL, Buszman PE; Controlled Reperfusion with Intravenous Bivalirudin and Intracoronary Abciximab Combination Therapy in the Porcine Myocardial Infarction Model; Thromb Res. 2011 Nov 11. [Epub ahead of print].

  70. Milewski K, Zurakowski A, Pajak J, Liszka L, Debinski M, Buszman PP, Samra MA, Dominek P, Aboodi MS, Kaluza GL, Buszman P; Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model; Cardiovasc Revasc Med. 2011 Mar-Apr;12(2):82-9. Epub 2010 Oct 20.